Sort   by:  
 Page size 
UnknownOutcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemia.
Not available
S-EPMC8189917 | biostudies-literature
UnknownAutologous myoblast transplantation for oculopharyngeal muscular dystrophy: a phase I/IIa clinical study.
Not available
S-EPMC3978797 | biostudies-literature
UnknownA new role of glutathione peroxidase 4 during human erythroblast enucleation.
Not available
S-EPMC7686909 | biostudies-literature
UnknownReducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a report by the French Belgian Swiss APL group (APL 2006 trial).
Not available
S-EPMC6278967 | biostudies-literature
UnknownA Phase II Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia.
Not available
S-EPMC5557033 | biostudies-literature
UnknownR-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma.
Not available
S-EPMC5757680 | biostudies-literature
UnknownCharacteristics and clinical outcomes of SARS-CoV-2 infection in adult patients with acute leukemia in France.
Not available
S-EPMC9212547 | biostudies-literature
Unknowndel(17p) without TP53 mutation confers a poor prognosis in intensively treated newly diagnosed patients with multiple myeloma.
Not available
S-EPMC7933766 | biostudies-literature
UnknownHeterogeneity in long-term outcomes for patients with Revised International Staging System stage II, newly diagnosed multiple myeloma.
Not available
S-EPMC10153521 | biostudies-literature
UnknownClinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.
Not available
S-EPMC2343588 | biostudies-literature
Sort   by:  
 Page size